ASKA Pharmaceutical Holdings Co (TSE:4886) Total Liabilities : 円34,467 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is ASKA Pharmaceutical Holdings Co Total Liabilities?

ASKA Pharmaceutical Holdings Co's Total Liabilities for the quarter that ended in Dec. 2023 was 円34,467 Mil.

ASKA Pharmaceutical Holdings Co's quarterly Total Liabilities increased from Jun. 2023 (円32,288.00 Mil) to Sep. 2023 (円33,301.00 Mil) and increased from Sep. 2023 (円33,301.00 Mil) to Dec. 2023 (円34,467.00 Mil).

ASKA Pharmaceutical Holdings Co's annual Total Liabilities declined from Mar. 2022 (円34,406.00 Mil) to Mar. 2023 (円32,607.00 Mil) and declined from Mar. 2023 (円32,607.00 Mil) to Mar. 2024 (円28,816.00 Mil).

ASKA Pharmaceutical Holdings Co Total Liabilities Historical Data

The historical data trend for ASKA Pharmaceutical Holdings Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ASKA Pharmaceutical Holdings Co Total Liabilities Chart

ASKA Pharmaceutical Holdings Co Annual Data

Trend

Mar22

Mar23

Mar24

Total Liabilities

34,406.00

32,607.00

28,816.00

ASKA Pharmaceutical Holdings Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial							32,607.00	32,288.00	33,301.00	34,467.00	28,816.00

ASKA Pharmaceutical Holdings Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ASKA Pharmaceutical Holdings Co's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	23968	+	(4505	+	343
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	28,816

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	90745	-	61929
	=	28,816

ASKA Pharmaceutical Holdings Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	21520	+	(6925	+	342
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	5680)
	=	34,467

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	94857	-	60390
	=	34,467

ASKA Pharmaceutical Holdings Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of ASKA Pharmaceutical Holdings Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

ASKA Pharmaceutical Holdings Co (TSE:4886) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ASKA Pharmaceutical Holdings Co Ltd (TSE:4886) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-5-1 Shibaura, Minato-ku, Tokyo, JPN, 108-8532

Website

https://www.aska-pharma-hd.co.jp

ASKA Pharmaceutical Holdings Co Ltd is engaged in the manufacturing, sale, import, export, clinical examinations and testing operations of pharmaceuticals, quasi-drugs, foods, veterinary drugs, feeds and feed additives and medical devices and related operations.

ASKA Pharmaceutical Holdings Co (TSE:4886) Headlines

No Headlines